Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65 - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65

Authors list: Lorenz, Birgit; Preising, Markus N.; Scholz, Johanna Pauline; Kuenzel, Sandrine H.; Herrmann, Philipp; Holz, Frank G.

Publication year: 2023

Journal: Investigative Ophthalmology & Visual Science

Volume number: 64

Issue number: 8

ISSN: 0146-0404

eISSN: 1552-5783

Conference: Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Publisher: Association for Research in Vision and Ophthalmology

Citation Styles

Harvard Citation style: Lorenz, B., Preising, M., Scholz, J., Kuenzel, S., Herrmann, P. and Holz, F. (2023) Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65, Investigative Ophthalmology & Visual Science, 64(8)

APA Citation style: Lorenz, B., Preising, M., Scholz, J., Kuenzel, S., Herrmann, P., & Holz, F. (2023). Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65. Investigative Ophthalmology & Visual Science. 64(8).